195 related articles for article (PubMed ID: 28357271)
1. Yeast proteinopathy models: a robust tool for deciphering the basis of neurodegeneration.
Shrestha A; Megeney LA
Microb Cell; 2015 Nov; 2(12):458-465. PubMed ID: 28357271
[TBL] [Abstract][Full Text] [Related]
2. Walking the tightrope: proteostasis and neurodegenerative disease.
Yerbury JJ; Ooi L; Dillin A; Saunders DN; Hatters DM; Beart PM; Cashman NR; Wilson MR; Ecroyd H
J Neurochem; 2016 May; 137(4):489-505. PubMed ID: 26872075
[TBL] [Abstract][Full Text] [Related]
3. Cellular Proteostasis in Neurodegeneration.
Kurtishi A; Rosen B; Patil KS; Alves GW; Møller SG
Mol Neurobiol; 2019 May; 56(5):3676-3689. PubMed ID: 30182337
[TBL] [Abstract][Full Text] [Related]
4. Isolating potentiated Hsp104 variants using yeast proteinopathy models.
Jackrel ME; Tariq A; Yee K; Weitzman R; Shorter J
J Vis Exp; 2014 Nov; (93):e52089. PubMed ID: 25407485
[TBL] [Abstract][Full Text] [Related]
5. Engineering enhanced protein disaggregases for neurodegenerative disease.
Jackrel ME; Shorter J
Prion; 2015; 9(2):90-109. PubMed ID: 25738979
[TBL] [Abstract][Full Text] [Related]
6. Changes in proteome solubility indicate widespread proteostatic disruption in mouse models of neurodegenerative disease.
Pace MC; Xu G; Fromholt S; Howard J; Crosby K; Giasson BI; Lewis J; Borchelt DR
Acta Neuropathol; 2018 Dec; 136(6):919-938. PubMed ID: 30140941
[TBL] [Abstract][Full Text] [Related]
7. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.
Tenreiro S; Munder MC; Alberti S; Outeiro TF
J Neurochem; 2013 Nov; 127(4):438-52. PubMed ID: 23600759
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic targeting of mitochondria-proteostasis axis by antioxidant polysaccharides in neurodegeneration.
Wang Q; Adil MZ; Xie X; Zhao S; Zhang J; Huang Z
Adv Protein Chem Struct Biol; 2023; 136():385-413. PubMed ID: 37437985
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.
Reis SD; Pinho BR; Oliveira JMA
Mol Neurobiol; 2017 Oct; 54(8):5829-5854. PubMed ID: 27660272
[TBL] [Abstract][Full Text] [Related]
10. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.
Outeiro TF; Giorgini F
Biotechnol J; 2006 Mar; 1(3):258-69. PubMed ID: 16897706
[TBL] [Abstract][Full Text] [Related]
11. Emerging Targets and Latest Proteomics Based Therapeutic Approaches in Neurodegenerative Diseases.
Fatima MT; Islam Z; Ahmad E; Salahuddin P
Curr Protein Pept Sci; 2018; 19(9):858-875. PubMed ID: 28762306
[TBL] [Abstract][Full Text] [Related]
12. Protein-Remodeling Factors As Potential Therapeutics for Neurodegenerative Disease.
Jackrel ME; Shorter J
Front Neurosci; 2017; 11():99. PubMed ID: 28293166
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases.
Gao J; Wang L; Liu J; Xie F; Su B; Wang X
Antioxidants (Basel); 2017 Apr; 6(2):. PubMed ID: 28379197
[TBL] [Abstract][Full Text] [Related]
14. [Immunotherapy targeting misfolded proteins in neurodegenerative disease].
Kanemaru K
Brain Nerve; 2013 Apr; 65(4):469-74. PubMed ID: 23568995
[TBL] [Abstract][Full Text] [Related]
15. Prions, prion-like prionoids, and neurodegenerative disorders.
Verma A
Ann Indian Acad Neurol; 2016; 19(2):169-74. PubMed ID: 27293325
[TBL] [Abstract][Full Text] [Related]
16. TDP-43 in amyotrophic lateral sclerosis - is it a prion disease?
Ludolph AC; Brettschneider J
Eur J Neurol; 2015 May; 22(5):753-61. PubMed ID: 25846565
[TBL] [Abstract][Full Text] [Related]
17. Disruption of cellular proteostasis by H1N1 influenza A virus causes α-synuclein aggregation.
Marreiros R; Müller-Schiffmann A; Trossbach SV; Prikulis I; Hänsch S; Weidtkamp-Peters S; Moreira AR; Sahu S; Soloviev I; Selvarajah S; Lingappa VR; Korth C
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6741-6751. PubMed ID: 32152117
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.
Arai T; Hasegawa M; Nonoka T; Kametani F; Yamashita M; Hosokawa M; Niizato K; Tsuchiya K; Kobayashi Z; Ikeda K; Yoshida M; Onaya M; Fujishiro H; Akiyama H
Neuropathology; 2010 Apr; 30(2):170-81. PubMed ID: 20102522
[TBL] [Abstract][Full Text] [Related]
19. ALS Yeast Models-Past Success Stories and New Opportunities.
Di Gregorio SE; Duennwald ML
Front Mol Neurosci; 2018; 11():394. PubMed ID: 30425620
[TBL] [Abstract][Full Text] [Related]
20. Znf179 E3 ligase-mediated TDP-43 polyubiquitination is involved in TDP-43- ubiquitinated inclusions (UBI) (+)-related neurodegenerative pathology.
Lee YC; Huang WC; Lin JH; Kao TJ; Lin HC; Lee KH; Lin HC; Shen CJ; Chang WC; Huang CC
J Biomed Sci; 2018 Nov; 25(1):76. PubMed ID: 30404641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
